分子酶学和药物靶点

  • 期刊 h 指数: 5
  • 期刊引用分数: 0.57
  • 期刊影响因子: 0.58
索引于
  • 中国知网(CNKI)
  • 普布隆斯
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

By Preventing -Glucosidase and -Amylase Noncompetitively, Phenols from Sterculia Nobilis Smith Pericarp In-Products Postpone the Digestion of Carbohydrates

Pooja Bhatiya

The functional activity and phytochemical makeup of Sterculia Nobilis Smith pericarp, a byproduct of this tropical and subtropical fruit, have not received much attention. The LC-ESIMS/MS-MRM technique was employed in this study to analyse 16 phenolic compounds in the ethyl acetate fraction of the Sterculia Nobilis Smith pericarp extract on a qualitative and quantitative level. The main phenolic in the EAF were luteolin-7-O-glucoside, epicatechin gallate, and apigetrin. Models of inhibition of -glucosidase and -amylase were used to investigate the hypoglycemic action of EAF. With half-inhibitory concentration levels, EAF inhibited -glucosidase and -amylase activities in a reversible and non-competitive manner. The EAF's enzyme inhibition mechanism was investigated using spectroscopic techniques. The outcomes demonstrated that EAF changed the secondary structure and microenvironment of the enzymes' tyrosine and tryptophan residues. This study shows that the pericarp of Sterculia Nobilis Smith can be used as a low-cost raw material for the manufacturing of functional meals. Internal organ damage brought on by hyperglycemia can result in heart attacks, kidney failure, stroke, blindness, and kidney failure. As a result, diabetes has grown to be a serious hazard to human health and must be treated with long-term usage of hypoglycemic medications. These medications do have negative effects, though; include weight gain, upper respiratory tract infections, hypoglycemia, and gastrointestinal issues.

Keywords

Sterculia Nobilis Smith Pericarp; Phenolics; A-Glucosidase; A-Amylase; Postprandial Hyperglycemia

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证